Mechanisms of adenosine 5'-monophosphate catabolism in human erythrocytes.
Uncertainties regarding the role of pyrimidine nucleotidase (PyrNase) in AMP catabolism were resolved by studies of erythrocytes from normal controls, controls with young mean cell ages, and patients with hereditary hemolytic anemia due to severe deficiency of PyrNase. Hemolysates from the latter exhibited undiminished capacity to dephosphorylate AMP over a broad range of pH, indicating that PyrNase was not directly involved. In each subject group, the rates of AMP dephosphorylation between pH 5.1 and 8.3 were indistinguishable from those of IMP, suggesting a potential role for AMP-deaminase, an erythrocyte enzyme that was stimulated by coformycin at pH 7.2. Quantitative analysis of catabolites in incubated hemolysates confirmed that AMP degradation preferentially occurred via deamination to IMP with subsequent dephosphorylation by another erythrocyte nucleotidase isozyme, deoxyribonucleotidase. Both AMP-deaminase and deoxyribonucleotidase have acidic pH optima with minimal activities at physiologic pH, suggesting that this pathway of AMP catabolism could accelerate depletion of the adenine nucleotide pool and thereby mediate the demise of senescent erythrocytes sequestered in the spleen.
D015720:5'-Nucleotidase; D000249:Adenosine Monophosphate / Q000097:blood*; D003070:Coformycin / Q000494:pharmacology; D004906:Erythrocyte Count; D004912:Erythrocytes / Q000201:enzymology / Q000378:metabolism*; D006461:Hemolysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007291:Inosine Monophosphate / Q000097:blood; D009708:Nucleotidases / Q000172:deficiency; D010710:Phosphates / Q000096:biosynthesis; D010766:Phosphorylation; D012156:Reticulocytes / Q000378:metabolism / Q000473:pathology
D010710:Phosphates; D003070:Coformycin; D007291:Inosine Monophosphate; D000249:Adenosine Monophosphate; D009708:Nucleotidases; D015720:5'-Nucleotidase